Michael Jordan Friedman - 09 Mar 2021 Form 4 Insider Report for INNOVATIVE MEDTECH, INC. (IMTH)

Role
President, Director, 10%+ Owner
Signature
/s/ Michael Jordan Friedman
Issuer symbol
IMTH
Transactions as of
09 Mar 2021
Net transactions value
+$5,768,011
Form type
4
Filing time
23 Jun 2022, 16:01:28 UTC
Next filing
19 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMTH Common Stock Other $1.77 +17,694 $0.000100* 17,694 09 Mar 2021 Direct
transaction IMTH Series A Preferred Stock Other $0.424 +4,240 $0.000100* 4,240 09 Mar 2021 Direct
transaction IMTH Common Stock Other $34,009 +3,400,913 +19221% $0.0100* 3,418,607 25 Mar 2021 By Red Halo, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMTH Option Purchase $78,000 +50,000 $1.56 50,000 02 May 2022 Common Stock 50,000 $1.56 By Red Halo, LLC
transaction IMTH Option Purchase $156,000 +100,000 +200% $1.56 150,000 02 May 2022 Common Stock 100,000 $1.56 By Red Halo, LLC F1
transaction IMTH Option Purchase $300,000 +150,000 +100% $2.00 300,000 02 May 2022 Common Stock 150,000 $2.00 By Red Halo, LLC F1
transaction IMTH Option Purchase $600,000 +200,000 +67% $3.00 500,000 02 May 2022 Common Stock 200,000 $3.00 By Red Halo, LLC F1
transaction IMTH Option Purchase $1,000,000 +250,000 +50% $4.00 750,000 02 May 2022 Common Stock 250,000 $4.00 By Red Halo, LLC F1
transaction IMTH Option Purchase $1,500,000 +300,000 +40% $5.00 1,050,000 02 May 2022 Common Stock 300,000 $5.00 By Red Halo, LLC F1
transaction IMTH Option Purchase $2,100,000 +350,000 +33% $6.00 1,400,000 02 May 2022 Common Stock 350,000 $6.00 By Red Halo, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's Current Report on Form 8-K filed on May 27, 2022, these options are not exercisable until certain revenue milestones are met by the issuer.